Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

Sales of Eli Lilly’s diabetes and weight loss drugs fell far short of expectations in the third quarter, leading the juggernaut company to reduce its annual revenue guidance and triggering speculation ...

The company received A+ for growth and profitability ... driven by strong revenue growth in its GLP-1 tirzepatide franchise - ...

putting compounding of tirzepatide into a gray area. Meanwhile, semaglutide remains on the shortages list, but Novo Nordisk ...

When starting prescription weight loss medications, getting approval from a doctor and insurance is one of the hardest parts.

Shares of Viking Therapeutics (NASDAQ: VKTX) fell on Monday, Nov. 4, despite some encouraging new data. Over the weekend, the ...

Monday’s lawsuits from Eli Lilly are the first to be filed by the pharma since the regulator officially removed tirzepatide ...

That has been the case for these medications. But Novo Nordisk and Eli Lilly and Company, which makes tirzepatide, have continually warned that the copies are not equivalent to their FDA-approved ...